Ireland slow to approve cancer medicines for patient use

Just half of 41 cancer drugs approved from 2017-2020 were available here at end of 2021

State slower to ‘adopt new drugs’ than most of western Europe

Medicines regularly not worth approving at asking price

Covid-19 vaccine makers lobby EU for legal protection

Vaccine development in covid-era has been accelerated

Pharma lobby presses case for funding new medicines

PwC report on European drug sector highlights contributions to economy and society

May rounds on MPs as Brexit walls begin to close in

Business Week: also in the news were mortgages, housing, Google and McDonald’s

Drug companies warn of ‘hard Brexit’ risk to medicines in EU

Pharma chief says 45 million packs of medicines a month move from UK to EU

Most new drugs for treating rare diseases not approved for sale in Ireland

Pharma body says less than one-third of medicines for rare diseases licensed for patients in Europe are available in the Republic

Health Board: upcoming conferences, talks, campaigns and events

Price pressure keeps nine new drugs from Irish patients

Cancer drugs feature in list of therapies waiting HSE approval on cost grounds

Drugmakers warn Greek medicine supply ‘in jeopardy’

Pharma sector will continue supplies in July despite mounting unpaid bills but fears return of drachma

Educating advocates: how patients and parents can speak for change

Patients and parents of very ill or deceased children are learning about clinical trials, pharmacoeconomics and personalised medicines to become better patient advocates

Quarter of new drugs rejected for State schemes

Conference told innovative medicines must provide ‘real value for fair prices’